Quality of Life in Children With Psychiatric Disorders and Parental Well-being: Effects of Group CBT

NCT ID: NCT05808114

Last Updated: 2023-04-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

109 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-07-01

Study Completion Date

2019-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study examines the immediate and long-term effectiveness of a group cognitive behavioral therapy intervention (GCBT) in improving health-related quality of life (HRQOL) in children treated for mixed psychiatric disorders in naturalistic child psychiatric outpatient settings. The effects of a treatment-as-usual condition (TAU) is also examined. Further, the study aims to explore the associations among children“s HRQOL dimensions and parental well-being, and how GCBT may influence these associations.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The effectiveness of GCBT and TAU at the different time points are measured using nonparametric tests, such as Friedman tests and Wilcoxon tests. The associations among children“s HRQOL dimensions and parental well-being variables at different time points are explored using a network analysis approach.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Quality of Life

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group cognitive behavioral therapy

Friends Program

Group Type EXPERIMENTAL

Friends program

Intervention Type BEHAVIORAL

A GCBT intervention comprising ten weekly 60-minute sessions followed by two booster sessions

Treatment as Usual

A TAU condition during which participants received routine care services tailored to each child individually.

Group Type EXPERIMENTAL

TAU

Intervention Type BEHAVIORAL

Individually tailored and delivered specialized child psychiatric care

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Friends program

A GCBT intervention comprising ten weekly 60-minute sessions followed by two booster sessions

Intervention Type BEHAVIORAL

TAU

Individually tailored and delivered specialized child psychiatric care

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* child psychiatric outpatient care
* sufficient skills to participate in group sessions

Exclusion Criteria

* child psychiatric inpatient care
* acute suicidality
* excessive physical aggression
Minimum Eligible Age

6 Years

Maximum Eligible Age

13 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Helsinki University Central Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sarianna Barron-Linnankoski

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HUS/2699/2018

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.